鑫网易商(01039.HK):一买家终止认购附属股权
鑫网易商(01039.HK)公布,有关於视作出售於一间附属公司「分海」的股权的事宜,除北京信中利投资的认购事项外,余下两名其他投资者的认购事项已於2019年3月完成,集团已收到该认购事项所得款项总额2亿元人民币。
目前北京信中利投资的认购协议中的先决条件尚未完全达成或获豁免。因此,信中利投资认购协议应立即自动终止。信中利投资认购协议终止後,PCL和北京信中利投资应解除其根据信中利投资认购协议所承担的各自义务。
董事会认为,终止信中利投资认购协议不会对集团的业务营运或财务状况或公司及其股东的整体利益造成任何重大不利影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.